3Suppliers
8Customers
2Debt Items
20Related Chains

Source-Backed Evidence Depth

Corcept Therapeutics Incorporated (CORT) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

14Total relationships
3Distinct source URLs
7High confidence
0.768Average confidence
2026-10-30Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Corcept Therapeutics Incorporated Suppliers

TickerNameConfidenceEvidence
OPTIME-CARE-INC OPTIME-CARE-INC 90% the specialty pharmacy that previously served as our exclusive specialty pharmacy services vendor dispensing Korlym and the authorized generic version of Korlym and performing related pharmacy and pa…
BRK-B Berkshire Hathaway Inc. 80% Reciprocal relationship from BRK-B graph: Our other service businesses franchise and service a network of quick service restaurants (Dairy Queen), lease transportation equipment (XTRA) and furniture …
XERS Xeris Biopharma Holdings, Inc. 72% ol synthesis inhibitor osilodrostat to treat patients with Cushing’s disease, which approval was broadened in April 2025 to include adult patients with any etiology of hypercortisolism. 24 In 2021, X…

Corcept Therapeutics Incorporated Customers

TickerNameConfidenceEvidence
OPTIME-CARE-INC OPTIME-CARE-INC 85% Antitrust Litigation On June 13, 2024, Teva filed a complaint in the Northern District of California, captioned Teva Pharmaceuticals USA, Inc. v. Corcept Therapeutics, Inc., et al. (N.D. Cal.), Case …
TEVA-PHARMACEUTICALS-USA-INC TEVA-PHARMACEUTICALS-USA-INC 80% Teva filed a complaint in the Northern District of California, captioned Teva Pharmaceuticals USA, Inc. v. Corcept Therapeutics, Inc., et al.
XERS Xeris Biopharma Holdings, Inc. 72% range of disorders, including central serous retinopathy, post-traumatic stress disorder, anxiety, alcoholism, cocaine addiction, Alzheimer’s disease, ALS, hypercortisolism, metabolic syndrome, ather…
HEALTH-CARE-SERVICE-CORPORATION HEALTH-CARE-SERVICE-CORPORATION 70% several named plaintiffs filed a complaint against Corcept in the Alameda County Superior Court for the State of California, captioned, Aetna Inc., Health Care Service Corporation, Humana Inc. and Mo…
MOLINA-HEALTHCARE-INC MOLINA-HEALTHCARE-INC 70% several named plaintiffs filed a complaint against Corcept in the Alameda County Superior Court for the State of California, captioned, Aetna Inc., Health Care Service Corporation, Humana Inc. and Mo…
AETNA-INC-HEALTH-CARE-SERVICE-CORPORATION-HUMANA AETNA-INC-HEALTH-CARE-SERVICE-CORPORATION-HUMANA 62% Antitrust Litigation On June 13, 2024, Teva filed a complaint in the Northern District of California, captioned Teva Pharmaceuticals USA, Inc. v. Corcept Therapeutics, Inc., et al. (N.D. Cal.), Case …
HIKMA-PHARMACEUTICALS-USA-INC HIKMA-PHARMACEUTICALS-USA-INC 62% nge on appeal. Risks Related to our Stock • The price of our common stock fluctuates widely and is likely to continue to do so. Opportunities for investors to sell shares may be limited. • Our stock …
SUN-PHARMACEUTICAL-INDUSTRIES-LIMITED SUN-PHARMACEUTICAL-INDUSTRIES-LIMITED 62% nge on appeal. Risks Related to our Stock • The price of our common stock fluctuates widely and is likely to continue to do so. Opportunities for investors to sell shares may be limited. • Our stock …

Corcept Therapeutics Incorporated Debt Obligations

InstrumentDescriptionConfidenceEvidence
CORT-DEBT-8797 Xbrl Convertible 90% xbrl convertible detail from xbrl 2011-12-31.
CORT-DEBT Debt stack $9.6M 90% Market cache reports total debt of $9.6M.

Corcept Therapeutics Incorporated Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Corcept Therapeutics Incorporated.

Corcept Therapeutics Incorporated Ownership

HolderNameConfidenceEvidence
CORT-OWNER-BLACKROCK-INC BlackRock, Inc. 90% 13F overlay lists BlackRock, Inc. as top holder; 357 tracked holders.

Corcept Therapeutics Incorporated Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
XERS Xeris Biopharma Holdings, Inc. 100.00 1 ['customer', 'supplier']
BRK-B Berkshire Hathaway Inc. 100.00 1 ['supplier']
JEF Jefferies Financial Group Inc. 50.00 2
MKL Markel Group Inc. 50.00 2
PRI Primerica, Inc. 50.00 2
RYAN Ryan Specialty Holdings, Inc. 50.00 2
AA Alcoa Corporation 50.00 2
AIG American International Group, Inc. 50.00 2
AXP American Express Company 50.00 2
BBNX Beta Bionics, Inc. 50.00 2
HIG The Hartford Insurance Group, Inc. 50.00 2
L Loews Corporation 50.00 2
LCII LCI Industries 50.00 2
NEU NewMarket Corporation 50.00 2
OXY Occidental Petroleum Corporation 50.00 2
POR Portland General Electric Company 50.00 2
SSP The E.W. Scripps Company 50.00 2
DJCO Daily Journal Corporation 50.00 2
CNA CNA Financial Corporation 50.00 2
TEVJF Teva Pharmaceutical Industries Limited 50.00 2
🔐
CORT
Unlock CORT Supply Chain Data
Verified relationships include:
OPTIME-CARE-INCOPTIME-CARE-INCSupplier90%
BRK-BBerkshire Hathaway Inc.Supplier80%
OPTIME-CARE-INCOPTIME-CARE-INCCustomer85%
TEVA-PHARMACEUTICALS-USA-INCTEVA-PHARMACEUTICALS-USA-INCCustomer80%
+10 more relationships locked
Subscribe, View plans →